Results 311 to 320 of about 80,269 (322)

Expert Consensus on Clinical Applications of Fecal Microbiota Transplantation for Chronic Liver Disease (2025 edition). [PDF]

J Clin Transl Hepatol
Zhou Y, Yang L, Nan Y, Liver Related Digestive Diseases Group, Chinese Society of Hepatology, Chinese Medical Association.   +5 more
europepmc   +1 more source

Is Fecal Microbiota Transplantation Applicable for the Treatment of Irritable Bowel Syndrome? Time for Precision Medicine. [PDF]

J Neurogastroenterol Motil
Gweon TG.
europepmc   +1 more source

Fecal microbiota transplantation mitigates lipopolysaccharide-induced oxidative stress in weaned piglets by modulating gut microbiota and enhancing riboflavin metabolism. [PDF]

J Anim Sci Biotechnol
Ma J, Liu M, Xu J, Liu B, Cui Y, Shi Y.
europepmc   +1 more source

Long-Term Follow-Up After Fecal Microbiota Transplantation via Freeze-Dried Capsules for Recurrent <i>Clostridioides difficile</i> Infection. [PDF]

Pathog Immun
Hecker MT, Rosero C, Mendo-Lopez R, Wilson BM, Torres-Teran MM, Donskey CJ.   +5 more
europepmc   +1 more source

Correction to: Clostridioides difficile: Treating Sustained Antibiotic Responders With Fecal Microbiota Transplantation Does Not Improve Efficacy. [PDF]

Clin Infect Dis
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis

Science Translational Medicine, 2023
Immune checkpoint inhibitors (ICIs) target advanced malignancies with high efficacy but also predispose patients to immune-related adverse events like immune-mediated colitis (IMC).
Taylor M. Halsey, A. Thomas, Tomoyoshi Hayase, Weijie Ma, Hamzah Abu-Sbeih, Baohua Sun, E. Parra, Zhi-Dong Jiang, H. Dupont, Christopher A. Sanchez, Rawan K. El-Himri, Alexandria Brown, Ivonne I. Flores, Lauren A. L. McDaniel, Miriam R. Ortega Turrubiates, Matthew Hensel, D. Pham, S. Watowich, Eiko Hayase, Chia-Chi Chang, R. Jenq, Yinghong Wang   +21 more
semanticscholar   +1 more source

Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML

Journal of Clinical Oncology, 2023
PURPOSE Gut microbiota injury in allogeneic hematopoietic cell transplantation (HCT) recipients and patients with AML has been associated with adverse clinical outcomes.
A. Rashidi, M. Ebadi, T. Rehman, Heba Elhusseini, David Kazadi, Hossam Halaweish, M. H. Khan, Andrea Hoeschen, Q. Cao, Xianghua Luo, Amanda J. Kabage, Sharon Lopez, S. Holtan, D. Weisdorf, A. Khoruts, Christopher Staley   +15 more
semanticscholar   +1 more source

Fecal microbiota transplantation: current challenges and future landscapes

Clinical Microbiology Reviews
SUMMARY Given the importance of gut microbial homeostasis in maintaining health, there has been considerable interest in developing innovative therapeutic strategies for restoring gut microbiota. One such approach, fecal microbiota transplantation (FMT),
Abbas Yadegar, H. Bar-Yoseph, Tanya M Monaghan, S. Pakpour, Andrea Severino, E. Kuijper, W. Smits, E. Terveer, Sukanya Neupane, Ali Nabavi-Rad, Javad Sadeghi, Giovanni Cammarota, G. Ianiro, E. Nap-Hill, Dickson Leung, K. Wong, Dina Kao   +16 more
semanticscholar   +1 more source

Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial.

JAMA Neurology
Importance Dysbiosis has been robustly demonstrated in Parkinson disease (PD), and fecal microbiota transplantation (FMT) has shown promising effects in preclinical PD models.
F. Scheperjans, Reeta Levo, Berta Bosch, Mitja Lääperi, Pedro A. B. Pereira, Olli-Pekka Smolander, V. Aho, Nora Vetkas, Lotta Toivio, V. Kainulainen, Tatyana D Fedorova, P. Lahtinen, R. Ortiz, V. Kaasinen, Reetta Satokari, P. Arkkila   +15 more
semanticscholar   +1 more source